.jpeg "Experts Address API Manufacturing Quality at USP Convention 2025")
The 5th South Asia Regional Chapter Meeting during the USP Convention 2025 featured industry professionals and stakeholders gathering around key issues of improving the quality of Active Pharmaceutical Ingredient (API) production.
In order to buy its 47.84 percent share in J B Chemicals and Pharmaceuticals (JB Pharma), Gujarat-based Torrent Pharmaceuticals Limited has reopened negotiations with private equity (PE) company KKR
.jpeg "IRDAI 2024 Pushes for Robotic Surgeries, Surgeons Urge Coverage")
The IRDAI 2024 regulation making insurance coverage for robotic-assisted surgery (RAS) mandatory, top surgical societies in India are urging uniform implementation across health insurance companies
Nethradhama Super Speciality Eye Hospital, in association with Sun Pharma, organized a Cataract Awareness Cyclothon to promote early diagnosis and management of cataract. Cataracts are the leading cause of preventable blindness in India...
Biocon, an Indian biotech giant, has opted to withdraw plans to launch weight-loss drugs in China, reversing course as global growth for semaglutide-based weight-loss drugs builds. This decision comes as Novo Nordisk is also doubling down on its...
IMCD, world leader in specialty chemicals and formulation and distribution of ingredients, has acquired 100 percent of Trichem's equity, an Indian supplier of pharmaceuticals based in Mumbai.
In decisive move to fight the growing threat of counterfeit medicines, the Indian government has changed the Drugs Rules, 1945 to require barcodes or QR codes to be required on the packaging of certain high-risk medications...
.jpeg "Karnataka Govt Unveils 3-Year Plan to Strengthen Advanced Healthcare Access")
The Karnataka government has declared a grand three-year program to revamp the state's healthcare network by setting up super-specialty hospitals, trauma centres, and cancer treatment units in all 31 districts of the state.
The Indian government is set to limit open market access to key anti-tuberculosis medicines in order to contain misuse of critical medications that could lead to the emergence of drug resistance. This measure comes in light of the expiry of...
AstraZeneca, a biopharmaceutical company, announced on Thursday that it had invested Rs 166 crore to expand its global center in Bengaluru, adding 400 positions to support AI innovation, global services, and research & development.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")